Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approaches

C Guo, H Ashrafian, S Ghafur, G Fontana… - NPJ digital …, 2020 - nature.com
The field of digital health, and its meaning, has evolved rapidly over the last 20 years. For
this article we followed the most recent definition provided by FDA in 2020. Emerging …

A systematic review of coronavirus disease 2019 vaccine efficacy and effectiveness against severe acute respiratory syndrome coronavirus 2 infection and disease

MM Higdon, B Wahl, CB Jones… - Open Forum …, 2022 - academic.oup.com
Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …

Association between mRNA vaccination and COVID-19 hospitalization and disease severity

MW Tenforde, WH Self, K Adams, M Gaglani, AA Ginde… - Jama, 2021 - jamanetwork.com
Importance A comprehensive understanding of the benefits of COVID-19 vaccination
requires consideration of disease attenuation, determined as whether people who develop …

[HTML][HTML] Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization

DR Feikin, LJ Abu-Raddad, N Andrews, MA Davies… - Vaccine, 2022 - Elsevier
Vaccine effectiveness is lower and wanes faster against infection and symptomatic disease
caused by the omicron variant of SARS-CoV-2 than was observed with previous variants …

Capripoxvirus diseases: current status and opportunities for control

ESM Tuppurainen, EH Venter, JL Shisler… - Transboundary and …, 2017 - Wiley Online Library
Lumpy skin disease, sheeppox and goatpox are high‐impact diseases of domestic
ruminants with a devastating effect on cattle, sheep and goat farming industries in endemic …

[图书][B] Cluster randomised trials

RJ Hayes, LH Moulton - 2017 - taylorfrancis.com
Cluster Randomised Trials, Second Edition discusses the design, conduct, and analysis of
trials that randomise groups of individuals to different treatments. It explores the advantages …

COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact

DA Swan, C Bracis, H Janes, M Moore, L Matrajt… - Scientific reports, 2021 - nature.com
Trial results for two COVID-19 vaccines suggest at least 90% efficacy against symptomatic
disease (VEDIS). It remains unknown whether this efficacy is mediated by lowering SARS …

Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines

JA Lewnard, MM Patel, NP Jewell, JR Verani… - …, 2021 - journals.lww.com
Observational studies of the effectiveness of vaccines to prevent COVID-19 are needed to
inform real-world use. Such studies are now underway amid the ongoing rollout of SARS …

Containing pandemic influenza at the source

IM Longini Jr, A Nizam, S Xu, K Ungchusak… - Science, 2005 - science.org
Highly pathogenic avian influenza A (subtype H5N1) is threatening to cause a human
pandemic of potentially devastating proportions. We used a stochastic influenza simulation …

The (mis) estimation of neighborhood effects: causal inference for a practicable social epidemiology

JM Oakes - Social science & medicine, 2004 - Elsevier
The resurgence of interest in the effect of neighborhood contexts on health outcomes,
motivated by advances in social epidemiology, multilevel theories and sophisticated …